APO Research
Talk to an analyst

APO RESEARCH · REPORT

Midazolam Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Midazolam Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchMidazolam Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Midazolam Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Midazolam Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Midazolam Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Midazolam Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Midazolam Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Midazolam Injection include Yichang Humanwell Pharmaceutical, Sandoz, Jiangsu Nhwa Group, Pfizer, Fresenius Kabi, Sun Pharmaceutical, Hikma, Hameln Pharma and Avet Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Midazolam Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Midazolam Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Midazolam Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Midazolam Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Midazolam Injection Segment by Company

Yichang Humanwell Pharmaceutical

Sandoz

Jiangsu Nhwa Group

Pfizer

Fresenius Kabi

Sun Pharmaceutical

Hikma

Hameln Pharma

Avet Pharmaceuticals

Athenex

Akorn

Midazolam Injection Segment by Type

1mg/ml

5mg/ml

Midazolam Injection Segment by Application

Recovery Center

Hospital

Clinics

Midazolam Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Midazolam Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Midazolam Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Midazolam Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Midazolam Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Midazolam Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Midazolam Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Midazolam Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Midazolam Injection Industry Trends Table 2. Midazolam Injection Industry Drivers Table 3. Midazolam Injection Industry Opportunities and Challenges Table 4. Midazolam Injection Industry Restraints Table 5. Global Midazolam Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Midazolam Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Midazolam Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Midazolam Injection Sales Market Share by Manufacturers Table 9. Global Midazolam Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Midazolam Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Midazolam Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Midazolam Injection Manufacturers, Product Type & Application Table 13. Global Midazolam Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Midazolam Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1mg/ml Table 17. Major Manufacturers of 5mg/ml Table 18. Global Midazolam Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Midazolam Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Midazolam Injection Sales Market Share by Type (2021-2026) Table 22. Global Midazolam Injection Sales Market Share by Type (2027-2032) Table 23. Global Midazolam Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Midazolam Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Midazolam Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Midazolam Injection Revenue Market Share by Type (2021-2026) Table 27. Global Midazolam Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Recovery Center Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinics Table 31. Global Midazolam Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Midazolam Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Midazolam Injection Sales Market Share by Application (2021-2026) Table 35. Global Midazolam Injection Sales Market Share by Application (2027-2032) Table 36. Global Midazolam Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Midazolam Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Midazolam Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Midazolam Injection Revenue Market Share by Application (2021-2026) Table 40. Global Midazolam Injection Revenue Market Share by Application (2027-2032) Table 41. Global Midazolam Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Midazolam Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Midazolam Injection Sales Market Share by Region (2021-2026) Table 44. Global Midazolam Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Midazolam Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Midazolam Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Midazolam Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Midazolam Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Midazolam Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Midazolam Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Midazolam Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Midazolam Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Midazolam Injection Revenue Market Share by Region (2021-2026) Table 62. Global Midazolam Injection Revenue Market Share by Region (2027-2032) Table 63. Yichang Humanwell Pharmaceutical Company Information Table 64. Yichang Humanwell Pharmaceutical Business Overview Table 65. Yichang Humanwell Pharmaceutical Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolio Table 67. Yichang Humanwell Pharmaceutical Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sandoz Midazolam Injection Product Portfolio Table 72. Sandoz Recent Development Table 73. Jiangsu Nhwa Group Company Information Table 74. Jiangsu Nhwa Group Business Overview Table 75. Jiangsu Nhwa Group Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jiangsu Nhwa Group Midazolam Injection Product Portfolio Table 77. Jiangsu Nhwa Group Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Midazolam Injection Product Portfolio Table 82. Pfizer Recent Development Table 83. Fresenius Kabi Company Information Table 84. Fresenius Kabi Business Overview Table 85. Fresenius Kabi Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Fresenius Kabi Midazolam Injection Product Portfolio Table 87. Fresenius Kabi Recent Development Table 88. Sun Pharmaceutical Company Information Table 89. Sun Pharmaceutical Business Overview Table 90. Sun Pharmaceutical Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Midazolam Injection Product Portfolio Table 92. Sun Pharmaceutical Recent Development Table 93. Hikma Company Information Table 94. Hikma Business Overview Table 95. Hikma Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hikma Midazolam Injection Product Portfolio Table 97. Hikma Recent Development Table 98. Hameln Pharma Company Information Table 99. Hameln Pharma Business Overview Table 100. Hameln Pharma Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hameln Pharma Midazolam Injection Product Portfolio Table 102. Hameln Pharma Recent Development Table 103. Avet Pharmaceuticals Company Information Table 104. Avet Pharmaceuticals Business Overview Table 105. Avet Pharmaceuticals Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Avet Pharmaceuticals Midazolam Injection Product Portfolio Table 107. Avet Pharmaceuticals Recent Development Table 108. Athenex Company Information Table 109. Athenex Business Overview Table 110. Athenex Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Athenex Midazolam Injection Product Portfolio Table 112. Athenex Recent Development Table 113. Akorn Company Information Table 114. Akorn Business Overview Table 115. Akorn Midazolam Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Akorn Midazolam Injection Product Portfolio Table 117. Akorn Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Midazolam Injection Distributors List Table 121. Midazolam Injection Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Midazolam Injection Product Image Figure 2. Global Midazolam Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Midazolam Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Midazolam Injection Sales (2021-2032) & (K Units) Figure 5. Global Midazolam Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Midazolam Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1mg/ml Image Figure 9. 5mg/ml Image Figure 10. Global Midazolam Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Midazolam Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Midazolam Injection Sales Market Share by Type (2021-2032) Figure 13. Global Midazolam Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Midazolam Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Midazolam Injection Revenue Market Share by Type (2021-2032) Figure 16. Recovery Center Image Figure 17. Hospital Image Figure 18. Clinics Image Figure 19. Global Midazolam Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Midazolam Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Midazolam Injection Sales Market Share by Application (2021-2032) Figure 22. Global Midazolam Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Midazolam Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Midazolam Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Midazolam Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Midazolam Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Midazolam Injection Sales Market Share by Country (2021-2032) Figure 39. China Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Midazolam Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Midazolam Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Midazolam Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Midazolam Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Midazolam Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Midazolam Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Midazolam Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Midazolam Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Midazolam Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Midazolam Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg/ml
  • 5mg/ml
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • Yichang Humanwell Pharmaceutical
  • Sandoz
  • Jiangsu Nhwa Group
  • Pfizer
  • Fresenius Kabi
  • Sun Pharmaceutical
  • Hikma
  • Hameln Pharma
  • Avet Pharmaceuticals
  • Athenex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Midazolam Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Midazolam Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Midazolam Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Midazolam Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Midazolam Injection Market Dynamics
  1. 2.1 Midazolam Injection Industry Trends
  2. 2.2 Midazolam Injection Industry Drivers
  3. 2.3 Midazolam Injection Industry Opportunities and Challenges
  4. 2.4 Midazolam Injection Industry Restraints
3 Midazolam Injection Market by Manufacturers
  1. 3.1 Global Midazolam Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Midazolam Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Midazolam Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Midazolam Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Midazolam Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Midazolam Injection Manufacturers, Product Type & Application
  7. 3.7 Global Midazolam Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Midazolam Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Midazolam Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Midazolam Injection Tier 1, Tier 2, and Tier 3
4 Midazolam Injection Market by Type
  1. 4.1 Midazolam Injection Type Introduction
  2. 4.1.1 1mg/ml
  3. 4.1.2 5mg/ml
  4. 4.2 Global Midazolam Injection Sales by Type
  5. 4.2.1 Global Midazolam Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Midazolam Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Midazolam Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Midazolam Injection Revenue by Type
  9. 4.3.1 Global Midazolam Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Midazolam Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Midazolam Injection Revenue Market Share by Type (2021-2032)
5 Midazolam Injection Market by Application
  1. 5.1 Midazolam Injection Application Introduction
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.2 Global Midazolam Injection Sales by Application
  6. 5.2.1 Global Midazolam Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Midazolam Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Midazolam Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Midazolam Injection Revenue by Application
  10. 5.3.1 Global Midazolam Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Midazolam Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Midazolam Injection Revenue Market Share by Application (2021-2032)
6 Global Midazolam Injection Sales by Region
  1. 6.1 Global Midazolam Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Midazolam Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Midazolam Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Midazolam Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Midazolam Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Midazolam Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Midazolam Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Midazolam Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Midazolam Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Midazolam Injection Revenue by Region
  1. 7.1 Global Midazolam Injection Revenue by Region
  2. 7.1.1 Global Midazolam Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Midazolam Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Midazolam Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Midazolam Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Midazolam Injection Revenue (2021-2032)
  8. 7.2.2 North America Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Midazolam Injection Revenue (2021-2032)
  11. 7.3.2 Europe Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Midazolam Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Midazolam Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Midazolam Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Humanwell Pharmaceutical
  2. 8.1.1 Yichang Humanwell Pharmaceutical Company Information
  3. 8.1.2 Yichang Humanwell Pharmaceutical Business Overview
  4. 8.1.3 Yichang Humanwell Pharmaceutical Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolio
  6. 8.1.5 Yichang Humanwell Pharmaceutical Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Midazolam Injection Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Jiangsu Nhwa Group
  14. 8.3.1 Jiangsu Nhwa Group Company Information
  15. 8.3.2 Jiangsu Nhwa Group Business Overview
  16. 8.3.3 Jiangsu Nhwa Group Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Nhwa Group Midazolam Injection Product Portfolio
  18. 8.3.5 Jiangsu Nhwa Group Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Midazolam Injection Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Midazolam Injection Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Sun Pharmaceutical
  32. 8.6.1 Sun Pharmaceutical Company Information
  33. 8.6.2 Sun Pharmaceutical Business Overview
  34. 8.6.3 Sun Pharmaceutical Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharmaceutical Midazolam Injection Product Portfolio
  36. 8.6.5 Sun Pharmaceutical Recent Developments
  37. 8.7 Hikma
  38. 8.7.1 Hikma Company Information
  39. 8.7.2 Hikma Business Overview
  40. 8.7.3 Hikma Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Midazolam Injection Product Portfolio
  42. 8.7.5 Hikma Recent Developments
  43. 8.8 Hameln Pharma
  44. 8.8.1 Hameln Pharma Company Information
  45. 8.8.2 Hameln Pharma Business Overview
  46. 8.8.3 Hameln Pharma Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hameln Pharma Midazolam Injection Product Portfolio
  48. 8.8.5 Hameln Pharma Recent Developments
  49. 8.9 Avet Pharmaceuticals
  50. 8.9.1 Avet Pharmaceuticals Company Information
  51. 8.9.2 Avet Pharmaceuticals Business Overview
  52. 8.9.3 Avet Pharmaceuticals Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Avet Pharmaceuticals Midazolam Injection Product Portfolio
  54. 8.9.5 Avet Pharmaceuticals Recent Developments
  55. 8.10 Athenex
  56. 8.10.1 Athenex Company Information
  57. 8.10.2 Athenex Business Overview
  58. 8.10.3 Athenex Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Athenex Midazolam Injection Product Portfolio
  60. 8.10.5 Athenex Recent Developments
  61. 8.11 Akorn
  62. 8.11.1 Akorn Company Information
  63. 8.11.2 Akorn Business Overview
  64. 8.11.3 Akorn Midazolam Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Akorn Midazolam Injection Product Portfolio
  66. 8.11.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Midazolam Injection Value Chain Analysis
  2. 9.1.1 Midazolam Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Midazolam Injection Production Mode & Process
  6. 9.2 Midazolam Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Midazolam Injection Distributors
  9. 9.2.3 Midazolam Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst